hypericin has been researched along with Lung Neoplasms in 9 studies
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The tumoricidal properties of photodynamic therapy (PDT) with hypericin (HY) were evaluated in a highly metastatic adenocarcinoma (DA3Hi) and anaplastic squamous cell carcinoma (SQ2) tumors in vivo." | 3.70 | Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors. ( Blank, M; Keisari, Y; Lavie, G; Mandel, M, 2000) |
| "We report a case of "radiation recall dermatitis" (RRD) one year after RT as a result of taking hypericin (St." | 2.43 | Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature. ( Koelbl, O; Putnik, K; Schäfer, C; Stadler, P, 2006) |
| " Their biodistribution and pharmacokinetic properties were determined in rat models of induced necrosis." | 1.43 | Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones. ( Feng, Y; Gao, M; Huang, D; Jiang, C; Ni, Y; Shao, H; Sun, Z; Wang, X; Yang, S; Yin, Z; Zhang, D; Zhang, J, 2016) |
| "Moreover, we found that a subset of cancer patients of various cancer-types indeed possessed CALRlow or CRTlow-tumours." | 1.42 | Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal. ( Agostinis, P; de Witte, P; Elsen, S; Garg, AD; Krysko, DV; Vandenabeele, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kessel, D | 1 |
| Penjweini, R | 2 |
| Loew, HG | 1 |
| Breit, P | 1 |
| Kratky, KW | 1 |
| Smisdom, N | 1 |
| Deville, S | 1 |
| Ameloot, M | 1 |
| Garg, AD | 1 |
| Elsen, S | 1 |
| Krysko, DV | 1 |
| Vandenabeele, P | 1 |
| de Witte, P | 1 |
| Agostinis, P | 1 |
| Zhang, D | 1 |
| Jiang, C | 1 |
| Yang, S | 1 |
| Gao, M | 1 |
| Huang, D | 1 |
| Wang, X | 1 |
| Shao, H | 1 |
| Feng, Y | 1 |
| Sun, Z | 1 |
| Ni, Y | 1 |
| Zhang, J | 1 |
| Yin, Z | 1 |
| Gyurászová, K | 1 |
| Mikeš, J | 1 |
| Halaburková, A | 1 |
| Jendželovský, R | 1 |
| Fedoročko, P | 1 |
| Blank, M | 2 |
| Lavie, G | 2 |
| Mandel, M | 2 |
| Hazan, S | 1 |
| Orenstein, A | 1 |
| Meruelo, D | 1 |
| Keisari, Y | 2 |
| Putnik, K | 1 |
| Stadler, P | 1 |
| Schäfer, C | 1 |
| Koelbl, O | 1 |
1 review available for hypericin and Lung Neoplasms
| Article | Year |
|---|---|
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature.
Topics: Aged; Anthracenes; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Male; Perylene; Phytotherapy; R | 2006 |
8 other studies available for hypericin and Lung Neoplasms
| Article | Year |
|---|---|
Hypericin Accumulation as a Determinant of PDT Efficacy.
Topics: Animals; Anthracenes; Cell Line, Tumor; Humans; Lung Neoplasms; Mice; Perylene; Photochemotherapy; P | 2020 |
Optimizing the antitumor selectivity of PVP-Hypericin re A549 cancer cells and HLF normal cells through pulsed blue light.
Topics: Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Color; Dose-Re | 2013 |
Transport and accumulation of PVP-Hypericin in cancer and normal cells characterized by image correlation spectroscopy techniques.
Topics: Anthracenes; Cell Line, Tumor; Humans; Lung Neoplasms; Perylene; Photosensitizing Agents; Povidone; | 2014 |
Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Calreticulin; Cancer Vacc | 2015 |
Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.
Topics: Animals; Anthracenes; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Drug Design; | 2016 |
YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anthracenes; Antineoplastic Agents; Autophagy; Caspase 3; Ce | 2016 |
Antimetastatic activity of the photodynamic agent hypericin in the dark.
Topics: Animals; Anthracenes; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Disease Mod | 2004 |
Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors.
Topics: Adenocarcinoma; Animals; Anthracenes; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous C | 2000 |